FIELD: medicine.
SUBSTANCE: study of biomaterials from primary and secondary lesions for identifying a infectious agent is conducted, as well as immunoglobulins IgG and kappa and lambda of free light chains (FLC) and for values of lambda FLC in spinal fluid ≥0.01 mcg/ml and kappa FLC ≥0.5 mcg/ml, in additional the antibodies to beta-2-glycoprotein-I, to endothelium, to complement factor Clq and cryoglobulins as cryocrit and rheumatoid factor activity are defined. If values of antibodies to beta-2-glycoprotein-I ≥5 U/ml and/or to endothelium ≥1:10 and/or to complement factor Clq ≥10 U/ml and/or to cryoglobulins as cryocrit >0% and/or rheumatoid factor activity ≥1:20 and when detecting chlamydia and/or pathogenic forms of bacteroids in cerebrospinal fluid and/or blood and/or in scrapings from nasal and/or conjunctiva vascular lesions of CNS is detected.
EFFECT: development of methods for determining vascular lesions of CNS associated with chlamydial infection.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR PERSISTENT LATENT BACTERIAL INFECTION WITH ASSOCIATING VESSEL WALL INVOLVEMENT | 2009 |
|
RU2414714C1 |
DIAGNOSTIC TECHNIQUE FOR CHRONIC LATENT CHLAMIDIA INFECTIONS IN CENTRAL NERVOUS SYSTEM | 2008 |
|
RU2361217C1 |
METHOD OF TREATING INFANTILE CEREBRAL PARALYSIS | 2008 |
|
RU2385746C1 |
METHOD FOR DETECTING RISK GROUPS ON DEVELOPING INTRAUTERINE CHLAMYDIAL INFECTION IN NEONATALS AT EARLY NEONATAL PERIOD | 2004 |
|
RU2285261C2 |
METHOD FOR RESTORING AND KEEPING FAMILY HEALTH | 2002 |
|
RU2230558C2 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR FORMS OF ACUTE INFLAMMATORY POLYNEUROPATHY AND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY WITH ACUTE ONSET | 2010 |
|
RU2432113C1 |
METHOD FOR SETTING SEROLOGICAL DIAGNOSIS OF ACTIVE CHLAMYDIA INFECTION IN PREGNANT WOMEN | 2004 |
|
RU2272293C1 |
METHOD OF DETERMINATION OF COMPLEX OF ETIOLOGICAL FACTORS LEADING TO DEVELOPMENT OF SPECIFIC CHRONIC INFLAMMATORY DISEASES OF ANTERIOR EYE CREST | 2007 |
|
RU2337609C2 |
METHOD FOR PREPARING HYPERIMMUNE RICKETTSIAL SERUMS | 2011 |
|
RU2482875C1 |
METHOD FOR EVALUATING THE AREAS OF CEREBRAL EPILEPTIC ACTIVITY | 2005 |
|
RU2294696C1 |
Authors
Dates
2010-07-10—Published
2008-05-15—Filed